Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Criteo S.A.CRTO · Entity 291 | Director | November 15, 2023 | November 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Criteo S.A.
Report date November 15, 2023 · Filed November 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 34,853 |
Reported balance
After 2023-11-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-11-15 · Grant · Acquired 7,300 · Balance 34,853 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.
F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2023 Filed Nov 21, 2023 16:00 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 7,300 | $24.39 | $178,047.00 |
DisclosureSEC source: 0001576427-23-000139 · wk-form4_1700600438.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,853 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 10,200 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · derivative · entry 6 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,200 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). F6 · derivative.exercise_date: Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 20,400 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · derivative · entry 5 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,400 shares Expires 2023-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). F5 · derivative.exercise_date: Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 10,200 | $25.90 | $264,180.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 4 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,553 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 10,200 | $10.29 | $104,958.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 20,400 | $25.90 | $528,360.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,553 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 16:16 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 20,400 | $10.29 | $209,916.00 |
DisclosureSEC source: 0001576427-22-000130 · wf-form4_167113893470134.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 16:07 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 174 | $26.41 | $4,595.34 |
DisclosureSEC source: 0001576427-22-000104 · wf-form4_166871920088819.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,553 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F4 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 16:07 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 6,479 | $26.28 | $170,268.12 |
DisclosureSEC source: 0001576427-22-000104 · wf-form4_166871920088819.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,379 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.20 to $26.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:21 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 4,270 | $39.95 | $170,585.22 |
DisclosureSEC source: 0001576427-21-000078 · wf-form4_163977605449916.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:21 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 110 | $38.88 | $4,276.25 |
DisclosureSEC source: 0001576427-21-000078 · wf-form4_163977605449916.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,630 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| November 24, 2020 Filed Nov 30, 2020 16:16 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 9,270 | $18.87 | $174,924.90 |
DisclosureSEC source: 0001576427-20-000111 · wf-form4_160677094971134.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,520 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.86 to $19.11, inclusive. The reporting person undertakes to provide to any security holder of Criteo S.A. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 7,250 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001576427-20-000092 · wf-form4_160097774985732.xml · derivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.81 using the Federal Reserve Bank of New York noon buying rate for September 18, 2020 (1.00 = $1.1857). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 7,250 | $0.81 | $5,872.50 |
DisclosureSEC source: 0001576427-20-000092 · wf-form4_160097774985732.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.81 using the Federal Reserve Bank of New York noon buying rate for September 18, 2020 (1.00 = $1.1857). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 16:07 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 26,420 | $7.57 Strike: $19.41 | $199,999.40 |
DisclosureSEC source: 0001576427-19-000094 · wf-form4_157229322120319.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,420 Underlying: Ordinary Shares · Not disclosed shares Expires 2029-10-23 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 Euros. The U.S. dollar equivalent of the exercise price is $19.41 using the European Central Bank rate as of October 22, 2019 (1.00 = $1.1130), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.57. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 24, 2020 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:13 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 25,000 | $7.87 Strike: $22.45 | $196,750.00 |
DisclosureSEC source: 0001576427-18-000087 · wf-form4_154214359835831.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2028-10-25 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:29 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058303 · doc4.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for October 13, 2017 (1.00 = $1.1837). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $45.97 | $57,462.50 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.83 | $1,037.50 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for October 13, 2017 (1.00 = $1.1837). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.84 using the Federal Reserve Bank of New York noon buying rate for September 8, 2017 (1.00 = $1.2041). F5 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $42.21 | $52,762.50 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.84 | $1,050.00 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.84 using the Federal Reserve Bank of New York noon buying rate for September 8, 2017 (1.00 = $1.2041). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,750 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for August 11, 2017 (1.00 = $1.1811). F5 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $51.49 | $64,362.50 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.83 | $1,037.50 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for August 11, 2017 (1.00 = $1.1811). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 19:36 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001209191-17-045761 · doc4.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.80 using the Federal Reserve Bank of New York noon buying rate for July 14, 2017 (1.00 = $1.1452). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 19:36 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $50.46 | $63,075.00 |
DisclosureSEC source: 0001209191-17-045761 · doc4.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 19:36 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.80 | $1,000.00 |
DisclosureSEC source: 0001209191-17-045761 · doc4.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.80 using the Federal Reserve Bank of New York noon buying rate for July 14, 2017 (1.00 = $1.1452). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 16:09 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001576427-17-000114 · wf-form4_149790292991868.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.78 using the Federal Reserve Bank of New York noon buying rate for June 9, 2017 (1.00 = $1.1190). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 16:09 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $46.98 | $58,725.00 |
DisclosureSEC source: 0001576427-17-000114 · wf-form4_149790292991868.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 16:09 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.78 | $975.00 |
DisclosureSEC source: 0001576427-17-000114 · wf-form4_149790292991868.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.78 using the Federal Reserve Bank of New York noon buying rate for June 9, 2017 (1.00 = $1.1190). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:11 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001576427-17-000102 · wf-form4_149505185190416.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.76 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926). F4 · derivative.exercise_date: One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:11 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $53.54 | $66,925.00 |
DisclosureSEC source: 0001576427-17-000102 · wf-form4_149505185190416.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:11 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.76 | $950.00 |
DisclosureSEC source: 0001576427-17-000102 · wf-form4_149505185190416.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.76 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| May 05, 2017 Filed May 9, 2017 16:21 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,000 | $52.44 | $52,440.00 |
DisclosureSEC source: 0001576427-17-000089 · wf-form4_149436128329352.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 16:57 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001576427-17-000060 · wf-form4_149246266460564.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,750 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for April 14, 2017 (1.00 = $1.0625). F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 16:57 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,250 | $49.79 | $62,237.50 |
DisclosureSEC source: 0001576427-17-000060 · wf-form4_149246266460564.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 16:57 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,250 | $0.74 | $925.00 |
DisclosureSEC source: 0001576427-17-000060 · wf-form4_149246266460564.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for April 14, 2017 (1.00 = $1.0625). Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 16:16 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,000 | $48.70 | $48,700.00 |
DisclosureSEC source: 0001576427-17-000047 · wf-form4_148969540383403.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.57 to $48.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 16:56 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001576427-17-000019 · wf-form4_148823256154633.xml · derivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 1,000 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for February 24, 2017 (1.00 = $1.058) F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 16:56 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,000 | $0.74 | $740.00 |
DisclosureSEC source: 0001576427-17-000019 · wf-form4_148823256154633.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for February 24, 2017 (1.00 = $1.058) Read SEC document |
| February 18, 2017 Filed Feb 21, 2017 16:58 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001576427-17-000014 · wf-form4_148771430377786.xml · derivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Ordinary Shares · 1,000 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for February 17, 2017 (1.00 = $1.0614) F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 18, 2017 Filed Feb 21, 2017 16:58 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,000 | $0.74 | $740.00 |
DisclosureSEC source: 0001576427-17-000014 · wf-form4_148771430377786.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.74 using the Federal Reserve Bank of New York noon buying rate for February 17, 2017 (1.00 = $1.0614) Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 16:16 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,000 | $46.01 | $46,010.00 |
DisclosureSEC source: 0001576427-17-000010 · wf-form4_148727975162559.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.98 to $46.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 16:35 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001576427-17-000006 · wf-form4_148598492936831.xml · derivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 1,000 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.75 using the Federal Reserve Bank of New York noon buying rate for January 27, 2017 (1.00 = $1.069) F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 16:35 UTC | Criteo S.A. CRTO · Entity 291 | Exercise / conversionOrdinary Shares | 1,000 | $0.75 | $750.00 |
DisclosureSEC source: 0001576427-17-000006 · wf-form4_148598492936831.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the non-employee warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.75 using the Federal Reserve Bank of New York noon buying rate for January 27, 2017 (1.00 = $1.069) Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 16:25 UTC | Criteo S.A. CRTO · Entity 291 | SaleOrdinary Shares | 1,000 | $45.00 | $45,000.00 |
DisclosureSEC source: 0001576427-17-000002 · wf-form4_148477471663782.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 16:14 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 13,185 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001576427-16-000380 · wf-form4_147768565756566.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866) F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.